zeteletinib (BOS-172738) - Boston Pharma
Gavreto (pralsetinib) - Rigel
Retevmo (selpercatinib) - Eli Lilly
https://cslide.ctimeetingtech.com/esmo2025/attendee/confcal_2/presentation
 
K.S.Y. Cheung1; K.H. Wong1; C.H.G. Tang1; M.S. Li2; L. Mak2; Y.H. Li2; K.T. Lai2; K. Wong2; O.H. Chen1; W. Lai1; K. Mok1; S.T.F. Mok1; T.Y.J. Ng1; W. Wong1; B. Lam1; J.M.S. Leung1; M.P. Lee1; T.S.K. Mok2; H.H.F. Loong2
 
Jul 24, 2025
 
Prev Next